Advantageous Uses of Nanotechnology as a Method for Removing Cancerous Cells from the Brain

Abstract

Incidences of brain cancers across the globe as well as the associated costs continue to drastically climb, contributing to over $80 billion per year of medical costs for cancer alone. With few options for treatment, the economic and societal impact of those affected desperately desire a safer, more efficient, and more cost-effective option for high-rate remission with minimal side effects. As targeted therapy treatment options have become a better option for cancer treatment, we believe that utilizing these current methods in combination with graphene, a highly diverse biomaterial, programmed nanoparticles could potentially play a large role in cancer research and treatment in the near future that may minimize the negative impact cancer has on society. Through injection into the cerebrospinal fluid, roughly one-hundred nanobots would be contained within a simple saline solution to be given a direct line of access into the brain. These nanoparticles comprised of graphene would ideally carry out similar functions to that of a killer T-Cell, as seen in the human body, as a method to target specific identified and marked cancerous cells. Once these nanobots have reached the identified cell, the nanobots will release an incredibly small amount of chemotherapy into said cell to maximize the efficiency in which chemotherapy is delivered to invoke minimal side effects and consequences on the human body. In this analysis of the newly-rising cancer treatment method in the field of targeted therapy, our research attempts to shed light on this additional option for individuals suffering from brain cancers.